Jung-Hyun Kim, Ph.D., is a Senior Researcher and Principal Investigator at the Research Institute of the National Cancer Center, South Korea. Dr. Kim earned a Ph.D. in Biomedical Science and Technology from Konkuk University, where his doctoral research focused on mitochondrial apoptosis and MAPK signaling regulated by Bcl-2 family proteins. He completed postdoctoral training and held research associate positions at the Mitchell Cancer Institute, University of South Alabama, and the Johns Hopkins University School of Medicine. His research centers on oncogenic RNA splicing and epigenetic regulation related to treatment resistance in cancer and genetic diseases. He has authored numerous high-impact publications in journals such as Nature Communications, Journal of Clinical Investigation, Blood, and Molecular Cell, contributing significantly to the understanding of SON- and HMGA1-mediated transcriptional and splicing networks in tumorigenesis.